Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes
- 1 March 2004
- journal article
- Published by Elsevier in Toxicology
- Vol. 196 (1-2) , 41-55
- https://doi.org/10.1016/j.tox.2003.11.002
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, CanadaScience of The Total Environment, 2003
- Waterborne and sediment toxicity of fluoxetine to select organismsPublished by Elsevier ,2003
- Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environmentChemosphere, 2003
- Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicityWater Research, 2002
- Method development for measuring trace levels of penicillins in aqueous environmental samplesRapid Communications in Mass Spectrometry, 2001
- Multiple variants of the peroxisome proliferator-activated receptor (PPAR) γ are expressed in the liver of Atlantic salmon (Salmo salar)Gene, 2000
- Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathwaysBiochemical Pharmacology, 1999
- Occurrence and Fate of the Pharmaceutical Drug Diclofenac in Surface Waters: Rapid Photodegradation in a LakeEnvironmental Science & Technology, 1998
- Gadolinium chloride reduces cytochrome P450: Relevance to chemical-induced hepatotoxicityToxicology, 1997
- Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced HepatocarcinogenesisHuman & Experimental Toxicology, 1994